Skin laxity and sagging

A 2026 systematic review covering 41 studies (15 RCTs) across skin types found consistent improvement in mild to moderate facial and neck laxity and texture. The honest scale of the effect matters: in comparative work, a single RF microneedling session achieved roughly 37 percent of the laxity improvement of a surgical facelift, so expect tightening measured in subtle grades over multiple sessions, not a lift.

A 2020 systematic review and meta-analysis (17 studies, 477 participants) found HIFU improves face and neck laxity with mean objective improvement of 2.74 and satisfaction of 2.68 on 5-point scales, real but moderate change. A 2025 systematic review reported laxity improvements of roughly 18 to 30 percent, best in the lower face and neck, with results declining in people with severe laxity or BMI over 30. Expect a subtle lift visible at 3 to 6 months, not a surgical result.

Measurable skin tightening after fractional CO2 has been quantified with mechanical skin testing, and expert panels report using it off the face for mild laxity, but the tightening effect is modest and there are no large controlled trials showing it competes with surgical or even ultrasound-based lifting. Clinics selling CO2 as a laser facelift are overselling; it firms texture more than it lifts.

PLLA is increasingly marketed for skin firmness and laxity on the face, neck, and body (including off-label buttock treatment) on the logic that new collagen tightens tissue. The 2025 systematic review notes improvements in skin quality measures in some included studies, but these are mostly small, uncontrolled, and secondary to volume outcomes. Randomized evidence that PLLA measurably tightens lax skin is thin.

Diluted and hyperdiluted CaHA is widely injected off-label as a biostimulator to firm crepey skin on the face, neck, and body. The 2024 systematic reviews covering face and body use state plainly that despite wide clinical adoption and a good safety record, the diluted and hyperdiluted protocols are not yet supported by randomized controlled trials; evidence is mostly case series and consensus opinion.

Profhilo is marketed heavily for laxity of the face, neck, and body. A 2026 systematic review of 9 studies with 278 participants reported improvements in laxity, elasticity, hydration, and density, but the included studies were mostly small, open-label, and lacked placebo controls, and Profhilo is not FDA approved in the US. Treat firmness claims as plausible but unproven at the controlled-trial level.

Some marketing claims cryolipolysis tightens skin as it removes fat. The support is thin: the 3D imaging study measured a small 1.29 square centimeter reduction in skin surface area alongside fat loss, which is retraction, not a tightening treatment. A 2025 meta-analysis of health outcomes confirmed reduced adiposity measures at 3 months but a relatively high rate of minor adverse events, and no controlled study demonstrates a clinically meaningful laxity benefit. If loose skin is the problem, this is the wrong tool.

Some clinics market deoxycholic acid as tightening skin while it dissolves fat, and it is also used off-label on jowls and small body fat pockets. Trials assessed skin laxity mainly as a safety endpoint (checking it did not worsen after fat removal), not as an improvement outcome, and a 2024 systematic review of off-label submental and jowl use focused on managing complications rather than proving benefit. There is no controlled evidence that it tightens skin.